It is over 40 years since anti-dsDNA antibodies were first described in patients with lupus. A wide variety of methods for detecting these immunoglobulins have been established. In this review, we consider the utility and practical problems that the main assays present. The clinical correlations between anti-dsDNA antibodies and clinical activity in patients with lupus is discussed.
Gharavi AE , Chu JL , Elkon KB . Autoantibodies to intracellular proteins in human systemic lupus erythematosus are not due to random polyclonal B cell activation . Arthritis Rheum1988; 31: 1337–1345 .
2.
Miescher P , Straessle R . New serological methods for the detection of LE factor . Vox Surg1957; 2: 283–287 .
3.
Ceppelini R , Polli E , Celada F . A DNA-reaction factor in serum of a patient with lupus erythematosus diffusus . Proc Soc Exp Biol Med1957; 96: 572–574 .
4.
Robbins WC , Holman HR , Deicher H et al. Complement fixation with cell nuclei and DNA in lupus erythematosus . Proc Soc Exp Biol1957; 9: 575–579 .
5.
Seligmann M.Evidence in the serum of patients with systemic lupus erythematosus of a substance producing a precipitation reaction with DNA . (Original in French.) C R Soc Biol (Paris)1957; 245: 328–333 .
Liang MM , Sacher SA , Roberts WN , Esdaile JM . Measurement of systemic lupus erythematosus activity in clinical research . Arthritis Rheum1988; 31: 817–825 .
8.
Bombardier C , Gladman D , Urowitz MB et al. The development and validation of the SLE Disease Activity Index (SLEDAI) . Arthritis Rheum1992; 35: 630–640 .
9.
Vitali C , Bencivelli W , Isenberg DA et al. Disease activity in systemic lupus erythematosus: report of the consensus study group of the European workshop for rheumatology research . Clin Exp Rheumatol1992; 10: 541–547 .
10.
Gladman DD , Goldsmith CH , Urowitz MB et al. Sensitivity to change or 3 systemic lupus erythematosus disease activity indices: international validation . J Rheumatol1994; 21: 1468–1471 .
11.
Isenberg DA , Ramsey-Goldman R . Assessing patients with lupus: towards a drug responder index . Rheumatology1999; 38: 1045–1049 .
12.
Symmons DPM , Coppock JS , Bacon PA et al. Development of a computerised index of clinical disease activity in systemic lupus erythematosus . Q J Med1988; 69: 927–932 .
13.
Hay EM , Bacon PA , Gordon C et al. The BILAG index: a reliable and valid instrument for measuring clinical disease activity in systemic lupus erythematosus . Q J Med1993; 86: 447–458 .
14.
Isenberg D , Garton M , Reichlin MW , Reichlin M . Long term follow up of autoantibody profiles in black female lupus patients and clinical comparison with Caucasian and Asian patients . Br J Rheum1997; 36: 229–233 .
15.
Isenberg DA , Gordon C . From BILAG to BLIPS—disease activity assessment in lupus past, present and future . Lupus2000; 9: 651–654 .
16.
Ho A , Magder L , Barr S , Petri M . Decreases in anti-double stranded DNA levels are associated with concurrent flares in patients with systemic lupus erythematosus . Arthritis Rheum2001; 44: 2342–2349 .
17.
Isenberg DA , Ehrenstein MR , Longhurst C , Kalsi JK . The origin, sequence, structure and consequences of developing anti-DNA antibodies— a human perspective . Arthritis Rheum1994; 37: 169–180 .
18.
Isenberg DA , Ducheney C , Williams W et al. Measurement of anti-DNA antibodies: a reappraisal using five methods . Ann Rheum Dis1987; 46: 448–456 .
19.
Smeenk RJT . Measurement of antibodies to DNA. In Venrooij MJv , Maini RN (eds). Manual of Biological Markers of Disease. Kluwer Academic: Dordrecht , 1993, A8, pp 1–12.
20.
Smeenk R , Brinkman K , Van den Brink H , Swaak T . A comparison of assays used for the detection of antibodies to DNA . Clin Rheumatol1990; 9(Suppl 1): 63–72 .
21.
Brinkman K , Termaat R-M , Brink HGvd , Berden JHM , Smeenk RJT . The specificity of the anti-dsDNA ELISA . A closer look. J Immunol Meth1991; 139: 91–100 .
22.
Emlen W , Jarusiripipat P , Burdick G . A new ELISA for the detection of double-stranded DNA antibodies . J Immunol Meth1990; 132: 91–101 .
23.
Hylkema MN , Huygen H , Kramers C , Wal ThJvd , Jong Jd , Bruggen MCJv et al. Clinical evaluation of a modified ELISA, using photobiotinylated DNA, for the detection of anti-DNA antibodies . J Immunol Meth1994; 170: 93–102 .
24.
Gonzalez C , Pascual MK , Gonzalez-Buitrago JM . Lack of cross-reactivity of anti-DNA antibodies to ribonucleoproteins in a new commercial blot system for specific ANAs . Autoimmunity2000; 32: 129–132 .
25.
Joos TO , Schrenk M , HopflP et al. A microarray enzyme-linked immunosorbent assay for autoimmune diagnostics . Electrophoresis2000; 21: 2641–2650 .
26.
Hylkema MN , Bruggen MCJv , Hove Tt , Jong Jd , Swaak AJG , Berden JHM et al. Histone-containing immune complexes are to a large extent responsible for anti-dsDNA reactivity in the Farr assay of active SLE patients . J Autoimmun2000; 14: 159–168 .
27.
Feltkamp TEW , Kirkwood TBL , Maini RN , Aarden LA . The first international standard for antibodies to dsDNA . Ann Rheum Dis1988; 47: 740–746 .
28.
Bootsma H , Spronk P , Derksen R , Boer Gd , Wolters-Dicke H , Hermans J et al. Prevention of relapses in systemic lupus erythematosus . Lancet1995; 345: 1595–1599 .
